Medical comms - Press Releases

Date	Title	Company
06-Dec-2023	Rare disease patients are breaking down language and location barriers in a new online community	Sciensus
28-Nov-2023	NICE endorses only approved treatment for ultra-rare Wolman disease for children diagnosed under the age of two: Interview Opportunity	National Institute for Health and Care Excellence (NICE)
21-Nov-2023	Pioneering Belgian project ATHENA paves the way for Real-World Data reuse in research and personalized care.	ATHENA
21-Nov-2023	Immix Biopharma Announces FDA Approval of IND Application for CAR-T NXC-201, Enabling U.S. Patient Dosing	Immix Biopharma, Inc.
21-Nov-2023	Myricx Bio Enters into an Exclusive Antibody License Agreement with WuXi Biologics	Myricx Bio
17-Nov-2023	3M Reveals Solventum as New Name for Planned, Independent Health Care Company Following Spin-Off	3M
13-Nov-2023	Bloomsbury Genetic Therapies Celebrates its One Year Anniversary and Outlines Key Strategic and Operational Achievements since Launch	Bloomsbury Genetic Therapies
13-Nov-2023	OGT to premiere SureSeq™ Myeloid MRD panel at AMP	OGT, A Sysmex Group Company
13-Nov-2023	“Somewhat sustainable”: 85% of pharmaceutical businesses battling for greener future, new supply chain report finds.	LogiPharma
09-Nov-2023	Gilead Sciences launches awards to celebrate and amplify the impactful work of community-based organizations across Australia, Canada and Europe	Gilead Sciences
26-Oct-2023	Mtech Access are returning to ISPOR Europe this November	Mtech Access
18-Oct-2023	Inizio Engage launches new global powerhouse learning brand, Nazaré	Inizio Engage
17-Oct-2023	Babies with a low birthweight are four times more likely to develop fatty liver disease in later life, new study shows	, United European Gastroenterology (UEG)
17-Oct-2023	Scientists reverse drug resistance in prostate cancer by targeting 'hijacked' white blood cells	The Institute of Cancer Research
17-Oct-2023	Poolbeg Pharma Partners with a Nasdaq-Listed Biopharma Company on its Oral Delivery Platform	Poolbeg Pharma
17-Oct-2023	STORM Therapeutics Presented Novel Pre-Clinical Data on STC-15 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics	STORM Therapeutics Ltd
17-Oct-2023	PATIENTS DOSED WITH METHYLONE IN LONDON IN NEW CLINICAL TRIAL TO TREAT PTSD	Clerkenwell Health
17-Oct-2023	Bloomsbury Genetic Therapies Receives Orphan Drug Designations from the European Commission and the US FDA for BGT-NPC for the Treatment of Niemann-Pick Disease Type C and Provides Update on Type B Pre-IND Interaction with the US FDA	Bloomsbury Genetic Therapies Limited
17-Oct-2023	Data Dreamland Conference Brings Together Top Experts in Cost-Efficient Data Solutions	Scalefree International GmbH
17-Oct-2023	Navin Fluorine International Ltd. launches Navin Molecular: The new brand for its future-thinking CDMO business	Navin Fluorine International Ltd